Toxic Effects of Fumonisins, Deoxynivalenol and Zearalenone Alone and in Combination in Ducks Fed the Maximum EUTolerated Level.


Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
16 02 2021
Historique:
received: 25 01 2021
revised: 12 02 2021
accepted: 13 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 1 7 2021
Statut: epublish

Résumé

Toxic effects among fumonisins B (FB), deoxynivalenol (DON) and zearalenone (ZEN) administered alone and combined were investigated in 84-day-old ducks during force-feeding. 75 male ducks, divided into five groups of 15 animals, received daily during the meal a capsule containing the desired among of toxin. Treated animals received dietary levels of toxins equivalent to 20 mg FB1+FB2/kg (FB), 5 mg DON/kg (DON), 0.5 mg ZEN/kg (ZEN) and 20, 5 and 0.5 mg/kg of FB, DON and ZEN (FBDONZEN), respectively. Control birds received capsules with no toxin. After 12 days, a decrease in body weight gain accompanied by an increase in the feed conversion ratio was observed in ducks exposed to FBDONZEN, whereas there was no effect on performances in ducks exposed to FB, DON and ZEN separately. No difference among groups was observed in relative organ weight, biochemistry, histopathology and several variables used to measure oxidative damage and testicular function. A sphinganine to sphingosine ratio of 0.32, 1.19 and 1.04, was measured in liver in controls and in ducks exposed to FB and FBDONZEN, respectively. Concentrations of FB1 in liver were 13.34 and 15.4 ng/g in ducks exposed to FB and FBDONZEN, respectively. Together ZEN and its metabolites were measured after enzymatic hydrolysis of the conjugated forms. Mean concentrations of α-zearalenol in liver were 0.82 and 0.54 ng/g in ducks exposed to ZEN and FBDONZEN, respectively. β-zearalenol was 2.3-fold less abundant than α-zearalenol, whereas ZEN was only found in trace amounts. In conclusion, this study suggests that decreased performance may occur in ducks exposed to a combination of FB, DON and ZEN, but does not reveal any other interaction between mycotoxins in any of the other variables measured.

Identifiants

pubmed: 33669302
pii: toxins13020152
doi: 10.3390/toxins13020152
pmc: PMC7920068
pii:
doi:

Substances chimiques

Biomarkers 0
Fumonisins 0
Trichothecenes 0
Zearalenone 5W827M159J
deoxynivalenol JT37HYP23V

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Poult Sci. 2012 Apr;91(4):844-51
pubmed: 22399723
J Vet Diagn Invest. 1993 Jan;5(1):75-83
pubmed: 8466985
Poult Sci. 2012 Apr;91(4):852-61
pubmed: 22399724
Oxid Med Cell Longev. 2018 Jun 11;2018:9547613
pubmed: 29991976
Poult Sci. 1997 Sep;76(9):1239-47
pubmed: 9276886
Poult Sci. 1999 Nov;78(11):1499-505
pubmed: 10560820
Poult Sci. 2000 Oct;79(10):1378-84
pubmed: 11055840
Chem Biol Interact. 2009 Dec 10;182(2-3):239-44
pubmed: 19559689
Poult Sci. 2012 Mar;91(3):550-5
pubmed: 22334729
J Vet Diagn Invest. 1992 Jul;4(3):330-3
pubmed: 1515495
Avian Dis. 1995 Oct-Dec;39(4):879-86
pubmed: 8719224
Toxins (Basel). 2020 Aug 15;12(8):
pubmed: 32824220
Avian Dis. 1995 Jan-Mar;39(1):32-8
pubmed: 7794188
Theriogenology. 2013 Oct 1;80(6):557-64
pubmed: 23916251
Avian Dis. 1994 Jul-Sep;38(3):454-60
pubmed: 7832697
Int J Mol Sci. 2011;12(11):7996-8012
pubmed: 22174646
Toxins (Basel). 2013 Apr 29;5(5):912-25
pubmed: 23628787
Food Chem Toxicol. 2021 Feb;148:111968
pubmed: 33422601
Poult Sci. 2014 Sep;93(9):2220-6
pubmed: 25002547
Toxins (Basel). 2019 Oct 11;11(10):
pubmed: 31614665
Avian Dis. 1997 Jan-Mar;41(1):73-9
pubmed: 9087322
EFSA J. 2018 May 25;16(5):e05242
pubmed: 32625894
Lipids Health Dis. 2017 May 30;16(1):98
pubmed: 28558775
Poult Sci. 2015 Jun;94(6):1298-315
pubmed: 25840963
Front Physiol. 2019 Dec 12;10:1495
pubmed: 31920700
Vet Res. 2015 Sep 23;46:98
pubmed: 26394675
Sci Rep. 2019 Jul 11;9(1):10065
pubmed: 31296911
Toxicology. 2001 May 28;163(1):11-22
pubmed: 11376861
Toxins (Basel). 2016 Nov 24;8(12):
pubmed: 27886128
Toxins (Basel). 2020 Jun 07;12(6):
pubmed: 32517357
Avian Dis. 2012 Mar;56(1):120-7
pubmed: 22545537
Avian Dis. 1992 Apr-Jun;36(2):450-4
pubmed: 1627116
Chem Biol Interact. 2006 Mar 10;160(1):41-50
pubmed: 16413517
Toxins (Basel). 2019 Aug 02;11(8):
pubmed: 31382532
Chem Biol Interact. 2003 Jul 25;146(1):61-72
pubmed: 12902153
Poult Sci. 2005 Jan;84(1):22-8
pubmed: 15685938
J Anim Physiol Anim Nutr (Berl). 2006 Feb;90(1-2):32-7
pubmed: 16422767
Poult Sci. 2004 Aug;83(8):1287-93
pubmed: 15339002
Food Chem Toxicol. 2008 Sep;46(9):3213-8
pubmed: 18700162
Chem Biol Interact. 2006 Mar 10;160(1):51-60
pubmed: 16412405
Toxins (Basel). 2019 Jun 27;11(7):
pubmed: 31252650
Avian Dis. 2019 Dec;63(4):703-712
pubmed: 31865686

Auteurs

Céline Peillod (C)

ITAVI, Centre INRA Val de Loire, 37380 Nouzilly, France.

Marie Laborde (M)

ITAVI, Centre INRA Val de Loire, 37380 Nouzilly, France.

Angélique Travel (A)

ITAVI, Centre INRA Val de Loire, 37380 Nouzilly, France.

Amandine Mika (A)

ITAVI, Centre INRA Val de Loire, 37380 Nouzilly, France.

Jean Denis Bailly (JD)

Equipe Biosynthèse et toxicité des mycotoxines, ENVT, UMR Toxalim, Université de Toulouse, F-31076 Toulouse, France.

Didier Cleva (D)

Chêne Vert Conseil, Z Bellevue II, 35220 Chateaubourg, France.

Cyril Boissieu (C)

Chêne Vert Conseil, Z Bellevue II, 35220 Chateaubourg, France.

Jean Le Guennec (J)

Finalab, 4 bis rue Th. Botrel, BP 351, 22603 Loudéac CEDEX, France.

Olivier Albaric (O)

ONIRIS, Site de la Chantrerie, BP 40706, 44307 Nantes CEDEX 3, France.

Sophie Labrut (S)

ONIRIS, Site de la Chantrerie, BP 40706, 44307 Nantes CEDEX 3, France.

Pascal Froment (P)

Equipe GCR INRA-Physiologie de la Reproduction et des Comportements-UMR INRA-CNRS (UMR 6175)-Université François Rabelais de Tours, 37380 Nouzilly, France.

Didier Tardieu (D)

ENVT, Université de Toulouse, F-31076 Toulouse, France.

Philippe Guerre (P)

ENVT, Université de Toulouse, F-31076 Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH